Ernexa Therapeutics Inc. (ERNA) Shareholders’ equity 2016–2025
Ernexa Therapeutics Inc. (ERNA) shareholders’ equity at each fiscal year-end, per SEC filings.
$1.7MFY2025 · since FY2016: $3.8M → $1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.7M | -23.8% |
| FY2024 | $2.2M | -81.6% |
| FY2023 | $12.1M | — |
| FY2021 | $7.7M | -21.4% |
| FY2020 | $9.7M | +40.9% |
| FY2019 | $6.9M | +24.9% |
| FY2018 | $5.5M | +36.1% |
| FY2017 | $4.1M | +5.7% |
| FY2016 | $3.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice